GlucoTrack, Inc. (NASDAQ:GCTK) Sees Significant Growth in Short Interest

GlucoTrack, Inc. (NASDAQ:GCTK) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 106,200 shares, an increase of 8.3% from the March 31st total of 98,100 shares. Based on an average trading volume of 169,100 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.5% of the shares of the stock are short sold.

GlucoTrack Trading Down 4.5 %

Shares of GlucoTrack stock traded down $0.02 on Tuesday, hitting $0.54. The stock had a trading volume of 196,114 shares, compared to its average volume of 187,082. The stock has a 50 day moving average of $0.40 and a 200 day moving average of $0.28. The firm has a market capitalization of $14.32 million, a P/E ratio of -1.45 and a beta of 0.28. GlucoTrack has a twelve month low of $0.13 and a twelve month high of $0.99. The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.22 and a current ratio of 3.22.

GlucoTrack (NASDAQ:GCTK) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.10) EPS for the quarter.

Insiders Place Their Bets

In related news, Director Drew Sycoff bought 182,540 shares of the business’s stock in a transaction on Monday, April 22nd. The shares were purchased at an average price of $1.26 per share, for a total transaction of $230,000.40. Following the completion of the transaction, the director now directly owns 2,951,258 shares of the company’s stock, valued at approximately $3,718,585.08. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 17.70% of the company’s stock.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.